Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy.
Saved in:
| Title: | Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy. |
|---|---|
| Authors: | Georgy, Josh Thomas1 (AUTHOR), Regi, Soumya Susan2 (AUTHOR), Georgy, Rosh Varghese2 (AUTHOR), Sasidharan, Balu Krishna3 (AUTHOR), Joel, Anjana1 (AUTHOR), Philip, Deepa Susan Joy1 (AUTHOR), John, Ajoy Oommen1 (AUTHOR), Thumaty, Divya Bala1 (AUTHOR), Marimuthu, Praveen Kumar1 (AUTHOR), Jambunathan, Prashant1 (AUTHOR), Harikrishna, Kovilapu1 (AUTHOR), Thomas, Zachariah4 (AUTHOR), Rani, N. Jansi5 (AUTHOR), Tirkey, Amit Jiwan6 (AUTHOR), Thomas, Meera7 (AUTHOR), Isiah, Rajesh3 (AUTHOR), Singh, Ashish1 (AUTHOR) ashishsingh@cmcvellore.ac.in |
| Source: | Scientific Reports. 10/8/2025, Vol. 15 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20452322 |
|---|---|
| DOI: | 10.1038/s41598-025-19197-y |
